🎙️ We’re back with the fifth episode of Parkinson Weekly, hosted by Prof. Bas Bloem.

This week’s Article of the Week explores an exciting area of research:

In this episode, Professor Bas Bloem reviews two groundbreaking studies marking a major step forward in regenerative medicine for Parkinson’s disease: a Phase I trial of hES cell-derived dopaminergic neurons and a Phase I/II trial of iPS-cell-derived dopaminergic cells. He discusses the scientific progress, safety outcomes, and the potential of stem cell therapies to transform future Parkinson’s treatment.

👉 You can read the full articles below:

Phase I: https://www.nature.com/articles/s41586-025-08845-y 

Phase I/II: https://www.nature.com/articles/s41586-025-08700-0

And don’t forget, you can listen here:

Amazon Music: https://music.amazon.co.uk/podcasts/34ec09bc-c8b8-4a28-a12b-ca8aae3edd57/parkinson-weekly?ref=dm_sh_BpcE171Aj6Bvc6jQNKL90yl8o

Spotify: https://open.spotify.com/show/5FVqV671ESQ5VxbncsIxIS?si=a29cb8d5e72640de

Apple: https://podcasts.apple.com/gb/podcast/parkinson-weekly/id1836115672

Have a question you’d like Bas to answer in a future episode? Email us at parkinsonweekly@gmail.com – we’d love to hear from you.